Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.
about
Insights into Newer Antimicrobial Agents Against Gram-negative BacteriaCeftolozane/tazobactam for the treatment of complicated intra-abdominal infections.Novel antibiotics: are we still in the pre-post-antibiotic era?Basis for selecting optimum antibiotic regimens for secondary peritonitis.Ceftazidime-avibactam (CTZ-AVI) as a treatment for hospitalized adult patients with complicated intra-abdominal infections.[New antibiotics prior to approval: is this the end of the innovative stagnation?].
P2860
Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.
@en
type
label
Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.
@en
prefLabel
Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.
@en
P2860
P1476
Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.
@en
P2093
Fernando Gilsanz
Lorenzo Aguilar
P2860
P304
P356
10.1586/14787210.2014.950230
P577
2014-08-20T00:00:00Z